| Literature DB >> 35847597 |
Jing He1, Yang Zhang1, Kehui Ouyang2, Lingli Chen1, Wenya Meng1, Ying Zhang1, Wenjun Wang1.
Abstract
In this study, the essential oil (EO) was extracted by steam distillation from Chimonanthus nitens Oliv, and the extraction process was optimized by response surface methodology. The optimum process conditions are as follows: extraction time of 4.57 h, soaking time of 1.33 h, and solid-liquid ratio of 1 : 21.4. Under these conditions, the theoretical yield of EO is 1.5624%. The EO compounds were analyzed by gas chromatography-mass spectrometry (GC-MS). A total of 52 chemical components were detected, among which the content of 3-(4,8-dimethylnona-3,7-dienyl)-furan was the highest, accounting for 21.43% of the total peak area. The EO showed good antioxidant activity against 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS), and reducing power. In this study, we observed the protective effect of EO on ulcerative colitis (UC) induced by dextran sodium sulfate (DSS) in mice. EO effectively delayed weight loss and reduced DAI score. Histological examination also observed a significant reduction in damage in the EO group. The colon length of mice in DSS group was the shortest, and the colon length of mice in EO treatment group was longer than that in model group, but shorter than that in normal group (NOR : 8.17 ± 0.39 cm; DSS : 5.57 ± 0.93 cm; L - EO : 6.47 ± 0.78 cm; M - EO : 5.98 ± 0.58 cm; and H - EO : 6.1 ± 0.52 cm). The GSH activity in the L-EO and SASP groups was significantly higher than that in the DSS group (P < 0.01). SOD activity in L-EO and M-EO groups was also significantly higher than that in DSS treatment group (P < 0.01). MDA was decreased in the EO treatment groups and the SASP group (L-EO, H-EO, SASP: P < 0.01; M-EO: P < 0.05). MPO of EO treatment group was lower than that of model group (the L-EO group was not significant, M-EO: P < 0.05, H-EO: P < 0.05). This study shows that EO can effectively improve the symptoms of colitis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35847597 PMCID: PMC9279075 DOI: 10.1155/2022/9701938
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 7.310
Results of the BBD design for the extraction of essential oil from Chimonanthus nitens Oliv.
| Run | Extraction time | Soaking time | Material-to-liquid ratio | The yield of EO |
|---|---|---|---|---|
|
|
|
|
| |
| 1 | 3 | 0 | 1 : 20 | 1.45 |
| 2 | 5 | 0 | 1 : 20 | 1.508 |
| 3 | 3 | 2 | 1 : 20 | 1.485 |
| 4 | 5 | 2 | 1 : 20 | 1.55 |
| 5 | 3 | 1 | 1 : 15 | 1.45 |
| 6 | 5 | 1 | 1 : 15 | 1.505 |
| 7 | 3 | 1 | 1 : 25 | 1.47 |
| 8 | 5 | 1 | 1 : 25 | 1.513 |
| 9 | 4 | 0 | 1 : 15 | 1.425 |
| 10 | 4 | 2 | 1 : 15 | 1.475 |
| 11 | 4 | 0 | 1 : 25 | 1.45 |
| 12 | 4 | 2 | 1 : 25 | 1.495 |
| 13 | 4 | 1 | 1 : 20 | 1.56 |
| 14 | 4 | 1 | 1 : 20 | 1.55 |
| 15 | 4 | 1 | 1 : 20 | 1.562 |
| 16 | 4 | 1 | 1 : 20 | 1.547 |
| 17 | 4 | 1 | 1 : 20 | 1.54 |
ANOVA of response surface quadratic model for extraction yield of essential oil from Chimonanthus nitens Oliv.
| Variables | Sun of squares | df | Mean square |
|
| |
|---|---|---|---|---|---|---|
| Model | 0.031 | 9 | 0.003427 | 48.81 | <0.0001 | Significant |
|
| 0.006105 | 1 | 0.006105 | 86.94 | <0.0001 | |
|
| 0.003698 | 1 | 0.003698 | 52.66 | 0.0002 | |
|
| 0.0006661 | 1 | 0.0006661 | 9.49 | 0.0178 | |
|
| 0.00001225 | 1 | 0.00001225 | 0.17 | 0.6887 | |
|
| 0.000036 | 1 | 0.000036 | 0.51 | 0.4972 | |
|
| 0.00000625 | 1 | 0.00000625 | 0.089 | 0.7741 | |
|
| 0.0009664 | 1 | 0.0009664 | 13.76 | 0.0076 | |
|
| 0.006209 | 1 | 0.006209 | 88.42 | <0.0001 | |
|
| 0.011 | 1 | 0.011 | 163.07 | <0.0001 | |
| Residual | 0.0004916 | 7 | 0.00007022 | |||
| Lack of fit | 0.0001548 | 3 | 0.00005158 | 0.61 | 0.6418 | Not significant |
| Pure error | 0.0003368 | 4 | 0.0000842 | |||
|
| 0.9843 | |||||
| Adj | 0.9641 | |||||
| C.V. % | 0.56 | |||||
| Adep precision | 19.048 | |||||
| Cor total | 0.031 | 16 |
Figure 1Diagnostic plots of model adequacy. Normal % probability (a), predicted versus actual (b), and internally studentized residuals (c).
Figure 2Response surface and contour plots for the effect of independent variables on extraction yield of essential oil.
Figure 3Total ion flow chromatography of EO.
Composition and content of Chimonanthus nitens Oliv essential oil.
| Peak | Compound | CAS number | RT | Area (%) |
|---|---|---|---|---|
| 1 | 3-Carene | 13466-78-9 | 4.643 | 0.61 |
| 2 | Camphene | 79-92-5 | 4.974 | 2.08 |
| 3 | (1-Methylethyl)-4-methylene-Bicyclo[3.1.0]hexane | 3387-41-5 | 5.595 | 0.15 |
| 4 | (1S)-(1)- | 18172-67-3 | 5.825 | 0.27 |
| 5 | D-Limonene | 5989-27-5 | 6.974 | 0.30 |
| 6 | Eucalyptol | 470-82-6 | 7.100 | 4.8 |
| 7 | Terpinolene | 586-62-9 | 9.010 | 0.13 |
| 8 | (+)-2-Bornanone | 464-49-3 | 11.566 | 11.85 |
| 9 | (1R,2R,5R,E)-7-Ethylidene-1,2,8,8-tetramethylbicyclo[3.2.1]octane | 193695-14-6 | 18.073 | 0.43 |
| 10 | L-Bornyl acetate | 5655-61-8 | 18.539 | 3.45 |
| 11 | Terpineol | 93836-50-1 | 20.164 | 0.65 |
| 12 | (-)- | 20307-84-0 | 21.932 | 5.21 |
| 13 | Copaene | 3856-25-5 | 23.120 | 0.75 |
| 14 |
| 141-12-8 | 23.629 | 0.48 |
| 15 | Bicyclosesquiphellandrene | 54274-73-6 | 23.836 | 1.71 |
| 16 |
| 515-13-9 | 23.946 | 0.38 |
| 17 | 4,8,8-Trimethyl-2-methylene-4-vinylbicyclo[5.2.0]nonane | 242794-76-9 | 25.227 | 2.27 |
| 18 |
| 18252-46-5 | 26.026 | 0.24 |
| 19 | Hexahydronaphthalene | 267665-20-3 | 26.715 | 0.5 |
| 20 | Tetramethyl-cycloundecatriene | 1000062-61-9 | 26.869 | 1.17 |
| 21 |
| 28973-97-9 | 27.164 | 0.32 |
| 22 |
| 483-76-1 | 27.936 | 5.69 |
| 23 |
| 39029-41-9 | 28.106 | 0.5 |
| 24 | Methylenetricyclo-decane | 18252-44-3 | 28.319 | 1.00 |
| 25 | Aciphyllene | 87745-31-1 | 28.571 | 0.11 |
| 26 | Cyperene | 2387-78-2 | 29.069 | 0.25 |
| 27 |
| 1000425-19-8 | 29.249 | 0.18 |
| 28 | Hexahydro dimethyl naphthalene | 17627-24-6 | 29.457 | 1.65 |
| 29 | Bornyl isovalerate | 76-50-6 | 29.704 | 0.3 |
| 30 | Dimethyl octahydro naphthalene | 123123-37-5 | 30.306 | 0.54 |
| 31 | Cubenene | 29837-12-5 | 31.232 | 0.55 |
| 32 | Butadienyl dimethyl octane | 1000195-92-1 | 31.532 | 0.62 |
| 33 | Peroxydiene | 1000140-33-3 | 31.910 | 0.93 |
| 34 |
| 28305-60-4 | 33.136 | 2.22 |
| 35 | Longifolenaldehyde | 19890-84-7 | 33.360 | 10.51 |
| 36 | 3-(4,8-Dimethylnona-3,7-dienyl)-furan | 23262-34-2 | 34.214 | 21.43 |
| 37 | Neoclovene oxide | 1000163-73-4 | 35.194 | 3.6 |
| 38 | 2-Heptanone | 90165-09-6 | 36.513 | 0.14 |
| 39 | (+)-Epicubenol methylethyl | 19912-67-5 | 38.762 | 0.36 |
| 40 | Isoaromadendrene epoxide | 1000159-36-6 | 40.366 | 0.88 |
| 41 | 4-Hexen-1-ol | 1000221-57-6 | 40.618 | 0.37 |
| 42 | Tetramethyl-hexahydro-Benzopyran | 41678-32-4 | 41.017 | 0.14 |
| 43 | Dimethyl-2,3-diethenyl-1,5-cyclohexane | 74806-57-8 | 41.636 | 0.17 |
| 44 | 1-adamantyl methyl ester | 1000282-92-0 | 42.358 | 0.74 |
| 45 | Dimethylspiro cyclooctane | 77143-32-9 | 44.586 | 0.13 |
| 46 | Costol | 515-20-8 | 45.878 | 0.12 |
| 47 |
| 1000465-97-2 | 47.925 | 0.72 |
| 48 | Dimethyl cyclohexane | 74806-56-7 | 49.715 | 0.61 |
| 49 | Farnesol isomer | 1000108-92-4 | 49.977 | 0.14 |
| 50 | Cyclopropane carboxylate | 1000299-38-0 | 50.218 | 0.49 |
| 51 |
| 57-10-3 | 50.842 | 0.34 |
| 52 | Diethyl(1-aminocyclohexyl) phosphate | 56372-35-1 | 51.444 | 2.26 |
Figure 4Scavenging activities of EO on DPPH radical, ABTS radical, and reducing power in vitro. VC (vitamin C) was used as positive control; ∗∗P < 0.01, versus VC at the same concentration.
Figure 5The daily body weight changes and the disease activity index (DAI) in mice.
Figure 6The representative photographs of H&E staining (magnification: ×200) and scores of colonic mucosa of mice. ∗P < 0.05 and∗∗P < 0.01 vs. normal control; #P < 0.05 and##P < 0.01 vs. the DSS group.
Figure 7Effects of EO on the colon length of colitis in mice. ∗P < 0.05 and∗∗P < 0.01 vs. normal control; #P < 0.05 and##P < 0.01 vs. the DSS group.
Figure 8Effects of EO on the levels of MPO, MDA, GSH and SOD in colon tissue of colitis mice. ∗P < 0.05 and∗∗P < 0.01 vs. normal control; #P < 0.05 and##P < 0.01 vs. the DSS group.